Anmelden

Publikationen

Suche in 13061 Publikationen:

Zurücksetzen RSS
Zeitraum
11580 Publikation(en)
06.07.2022
Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
Nguyen H, Hampel B, Nuñez D, Battegay M, Hachfeld A, Bernasconi E, Calmy A, Cavassini M, Vernazza P, Fellay J, Rudolph H, Huber M, Leuzinger K, Perreau M, Scherrer A, Ramette A, Yerly S, Günthard H, Kouyos R, Kusejko K. Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group. Clin Infect Dis 2022; 74:2266.
06.07.2022
Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
06.07.2022

Clin Infect Dis 2022; 74:2266

Nguyen Huyen, Hampel Benjamin, Nuñez David Garcia, Battegay Manuel, Hachfeld Anna, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Vernazza Pietro, Fellay Jacques, Rudolph Hannes, Huber Michael, Leuzinger Karoline, Perreau Matthieu, Scherrer Alexandra, Ramette Alban Nicolas, Yerly Sabine, Günthard Huldrych F, Kouyos Roger D, Kusejko Katharina

Weiter
05.07.2022
Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab
Ligorio F, Huober J, Moscetti L, Janni W, Coccia-Portugal M, Corsetto P, Belfiore A, Lorenzini D, Daidone M, Vingiani A, Gianni L, Pupa S, Bianchini G, Pruneri G, Nuciforo P, de Azambuja E, Izquierdo M, Di Cosimo S, Verderio P, Ciniselli C, Pizzamiglio S, Castagnoli L, Dugo M, Galbardi B, Salgado R, Loi S, Michiels S, Triulzi T, Tagliabue E, El-Abed S, Vernieri C. Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab. J Natl Cancer Inst 2022
05.07.2022
Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab
05.07.2022

J Natl Cancer Inst 2022

Ligorio Francesca, Huober Jens, Moscetti Luca, Janni Wolfgang, Coccia-Portugal Maria Antonia, Corsetto Paola Antonia, Belfiore Antonino, Lorenzini Daniele, Daidone Maria Grazia, Vingiani Andrea, Gianni Luca, Pupa Serenella Maria, Bianchini Giampaolo, Pruneri Giancarlo, Nuciforo Paolo, de Azambuja Evandro, Izquierdo Miguel, Di Cosimo Serena, Verderio Paolo, Ciniselli Chiara Maura, Pizzamiglio Sara, Castagnoli Lorenzo, Dugo Matteo, Galbardi Barbara, Salgado Roberto, Loi Sherene, Michiels Stefan, Triulzi Tiziana, Tagliabue Elda, El-Abed Sarra, Vernieri Claudio

Weiter
04.07.2022
Wunsch nach assistiertem Suizid? Von der Aufgabe, auf der Seite des Lebens zu stehen
Nestor K. Wunsch nach assistiertem Suizid? Von der Aufgabe, auf der Seite des Lebens zu stehen. Imago Hominis 2022; 29:10-89-99.
04.07.2022
Wunsch nach assistiertem Suizid? Von der Aufgabe, auf der Seite des Lebens zu stehen
04.07.2022

Imago Hominis 2022; 29:10-89-99

Nestor Karen

Weiter
04.07.2022
Dynamics of disease characteristics and clinical management of critically ill COVID-19 patients over the time course of the pandemic: an analysis of the prospective, international, multicentre RISC-19-ICU registry.
Wendel-Garcia P, Moser A, Jeitziner M, Aguirre-Bermeo H, Arias-Sanchez P, Apolo J, Roche-Campo F, Franch-Llasat D, Kleger G, Schrag C, Pietsch U, Filipovic M, David S, Stahl K, Bouaoud S, Ouyahia A, Fodor P, Locher P, Siegemund M, Zellweger N, Cereghetti S, Schott P, Gangitano G, Wu M, Alfaro-Farias M, Vizmanos-Lamotte G, Ksouri H, Gehring N, Rezoagli E, Turrini F, Lozano-Gómez H, Carsetti A, Rodríguez-García R, Yuen B, Weber A, Castro P, Escos-Orta J, Dullenkopf A, Martín-Delgado M, Aslanidis T, Perez M, Hillgaertner F, Ceruti S, Franchitti Laurent M, Marrel J, Colombo R, Laube M, Fogagnolo A, Studhalter M, Wengenmayer T, Gamberini E, Buerkle C, Buehler P, Keiser S, Elhadi M, Montomoli J, Guerci P, Fumeaux T, Schuepbach R, Jakob S, Que Y, Hilty M, RISC-19-ICU Investigators. Dynamics of disease characteristics and clinical management of critically ill COVID-19 patients over the time course of the pandemic: an analysis of the prospective, international, multicentre RISC-19-ICU registry. Crit Care 2022; 26:199.
04.07.2022
Dynamics of disease characteristics and clinical management of critically ill COVID-19 patients over the time course of the pandemic: an analysis of the prospective, international, multicentre RISC-19-ICU registry.
04.07.2022

Crit Care 2022; 26:199

Wendel-Garcia Pedro David, Moser André, Jeitziner Marie-Madlen, Aguirre-Bermeo Hernán, Arias-Sanchez Pedro, Apolo Janina, Roche-Campo Ferran, Franch-Llasat Diego, Kleger Gian-Reto, Schrag Claudia, Pietsch Urs, Filipovic Miodrag, David Sascha, Stahl Klaus, Bouaoud Souad, Ouyahia Amel, Fodor Patricia, Locher Pascal, Siegemund Martin, Zellweger Nuria, Cereghetti Sara, Schott Peter, Gangitano Gianfilippo, Wu Maddalena Alessandra, Alfaro-Farias Mario, Vizmanos-Lamotte Gerardo, Ksouri Hatem, Gehring Nadine, Rezoagli Emanuele, Turrini Fabrizio, Lozano-Gómez Herminia, Carsetti Andrea, Rodríguez-García Raquel, Yuen Bernd, Weber Anja Baltussen, Castro Pedro, Escos-Orta Jesus Oscar, Dullenkopf Alexander, Martín-Delgado Maria C, Aslanidis Theodoros, Perez Marie-Helene, Hillgaertner Frank, Ceruti Samuele, Franchitti Laurent Marilene, Marrel Julien, Colombo Riccardo, Laube Marcus, Fogagnolo Alberto, Studhalter Michael, Wengenmayer Tobias, Gamberini Emiliano, Buerkle Christian, Buehler Philipp K, Keiser Stefanie, Elhadi Muhammed, Montomoli Jonathan, Guerci Philippe, Fumeaux Thierry, Schuepbach Reto A, Jakob Stephan M, Que Yok-Ai, Hilty Matthias Peter, RISC-19-ICU Investigators

Weiter
02.07.2022
Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
Tsintari V, Walter B, Fend F, Overkamp M, Rothermundt C, Lopez C, Schittenhelm M, Kampa-Schittenhelm K. Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS). BMC cancer 2022; 22:725.
02.07.2022
Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
02.07.2022

BMC cancer 2022; 22:725

Tsintari Vasileia, Walter Bianca, Fend Falko, Overkamp Mathis, Rothermundt Christian, Lopez Charles D, Schittenhelm Marcus, Kampa-Schittenhelm Kerstin

Weiter
01.07.2022
Stromal Notch ligands foster lymphopenia-driven functional plasticity and homeostatic proliferation of naive B cells.
Gómez Atria D, Gaudette B, Londregan J, Kelly S, Perkey E, Allman A, Srivastava B, Koch U, Radtke F, Ludewig B, Siebel C, Ryan R, Robertson T, Burkhardt J, Pear W, Allman D, Maillard I. Stromal Notch ligands foster lymphopenia-driven functional plasticity and homeostatic proliferation of naive B cells. J Clin Invest 2022; 132
01.07.2022
Stromal Notch ligands foster lymphopenia-driven functional plasticity and homeostatic proliferation of naive B cells.
01.07.2022

J Clin Invest 2022; 132

Gómez Atria Daniela, Gaudette Brian T, Londregan Jennifer, Kelly Samantha, Perkey Eric, Allman Anneka, Srivastava Bhaskar, Koch Ute, Radtke Freddy, Ludewig Burkhard, Siebel Christian W, Ryan Russell Jh, Robertson Tanner F, Burkhardt Janis K, Pear Warren S, Allman David, Maillard Ivan

Weiter
01.07.2022
Association of diabetes mellitus and admission glucose levels with outcome after endovascular therapy in acute ischaemic stroke in anterior circulation.
Genceviciute K, Goeldlin M, Kurmann C, Mujanovic A, Meinel T, Kaesmacher J, Seiffge D, Jung S, Mordasini P, Fischer U, Gralla J, Sarikaya H, Simonetti B, Antonenko K, Umarova R, Bally L, Arnold M, Heldner M. Association of diabetes mellitus and admission glucose levels with outcome after endovascular therapy in acute ischaemic stroke in anterior circulation. Eur J Neurol 2022; 29:2996-3008.
01.07.2022
Association of diabetes mellitus and admission glucose levels with outcome after endovascular therapy in acute ischaemic stroke in anterior circulation.
01.07.2022

Eur J Neurol 2022; 29:2996-3008

Genceviciute Kotryna, Goeldlin Martina B, Kurmann Christoph C, Mujanovic Adnan, Meinel Thomas Raphael, Kaesmacher Johannes, Seiffge David Julian, Jung Simon, Mordasini Pasquale, Fischer Urs, Gralla Jan, Sarikaya Hakan, Simonetti Barbara Goeggel, Antonenko Kateryna, Umarova Roza, Bally Lia, Arnold Marcel, Heldner Mirjam R

Weiter
01.07.2022
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
Cagol A, Schaedelin S, Barakovic M, Benkert P, Todea R, Rahmanzadeh R, Galbusera R, Lu P, Weigel M, Melie-Garcia L, Ruberte E, Siebenborn N, Battaglini M, Radue E, Yaldizli O, Oechtering J, Sinnecker T, Lorscheider J, Fischer-Barnicol B, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb J, Remonda L, Wagner F, Vargas M, Du Pasquier R, Lalive P, Pravatà E, Weber J, Cattin P, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C. Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis. JAMA Neurol 2022; 79:682-692.
01.07.2022
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
01.07.2022

JAMA Neurol 2022; 79:682-692

Cagol Alessandro, Schaedelin Sabine A, Barakovic Muhamed, Benkert Pascal, Todea Ramona-Alexandra, Rahmanzadeh Reza, Galbusera Riccardo, Lu Po-Jui, Weigel Matthias, Melie-Garcia Lester, Ruberte Esther, Siebenborn Nina, Battaglini Marco, Radue Ernst-Wilhelm, Yaldizli Ozgür, Oechtering Johanna, Sinnecker Tim, Lorscheider Johannes, Fischer-Barnicol Bettina, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Chan Andrew T, Salmen Anke, Pot Caroline, Bridel Claire, Zecca Chiara, Derfuss Tobias, Lieb Johanna Maria, Remonda Luca, Wagner Franca, Vargas Maria I, Du Pasquier Renaud A, Lalive Patrice H, Pravatà Emanuele, Weber Johannes, Cattin Philippe C, Gobbi Claudio, Leppert David, Kappos Ludwig, Kuhle Jens, Granziera Cristina

Weiter
01.07.2022
Introduction. Arteriovenous malformations in 2022: a state of the art.
Kim L, Bozinov O, Huang J, Lanzino G. Introduction. Arteriovenous malformations in 2022: a state of the art. Neurosurg Focus 2022; 53:E1.
01.07.2022
Introduction. Arteriovenous malformations in 2022: a state of the art.
01.07.2022

Neurosurg Focus 2022; 53:E1

Kim Louis J, Bozinov Oliver, Huang Judy, Lanzino Giuseppe

Weiter
01.07.2022
Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.
Roelcke U, Schwyzer L, Zeitlberger A, Hundsberger T. Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression. Oncology 2022; 101:145-152.
01.07.2022
Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.
01.07.2022

Oncology 2022; 101:145-152

Roelcke Ulrich, Schwyzer Lucia, Zeitlberger Anna Maria, Hundsberger Thomas

Weiter
01.07.2022
Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study.
Hatemi G, Mahr A, Takeno M, Kim D, Melikoğlu M, Cheng S, McCue S, Paris M, Chen M, Yazici Y. Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study. RMD Open 2022; 8
01.07.2022
Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study.
01.07.2022

RMD Open 2022; 8

Hatemi Gülen, Mahr Alfred, Takeno Mitsuhiro, Kim Doyoung, Melikoğlu Melike, Cheng Sue, McCue Shannon, Paris Maria, Chen Mindy, Yazici Yusuf

Weiter
28.06.2022
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial
Huober J, Zhang H, Restuccia E, Lambertini C, Gochitashvili N, Henschel V, Eiger D, Graupner V, Zhukova L, Pedrini J, Huggins-Puhalla S, Chang Y, Jarząb M, Niikura N, Barrios C, IMpassion050 Trial Investigators. Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial. J Clin Oncol 2022; 40:2946-2956.
28.06.2022
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial
28.06.2022

J Clin Oncol 2022; 40:2946-2956

Huober Jens, Zhang Hong, Restuccia Eleonora, Lambertini Chiara, Gochitashvili Nino, Henschel Volkmar, Eiger Daniel, Graupner Vilma, Zhukova Lyudmila, Pedrini José, Huggins-Puhalla Shannon L, Chang Yuan-Ching, Jarząb Michał, Niikura Naoki, Barrios Carlos H, IMpassion050 Trial Investigators

Weiter
27.06.2022
A multicomponent family support intervention in intensive care units: study protocol for a multicenter cluster-randomized trial (FICUS Trial).
Naef R, Filipovic M, Jeitziner M, von Felten S, Safford J, Riguzzi M, Rufer M. A multicomponent family support intervention in intensive care units: study protocol for a multicenter cluster-randomized trial (FICUS Trial). Trials 2022; 23:533.
27.06.2022
A multicomponent family support intervention in intensive care units: study protocol for a multicenter cluster-randomized trial (FICUS Trial).
27.06.2022

Trials 2022; 23:533

Naef Rahel, Filipovic Miodrag, Jeitziner Marie-Madlen, von Felten Stefanie, Safford Judith, Riguzzi Marco, Rufer Michael

Weiter
27.06.2022
Peripapillary Oxygenation and Retinal Vascular Responsiveness to Flicker Light in Primary Open Angle Glaucoma.
Türksever C, Todorova M. Peripapillary Oxygenation and Retinal Vascular Responsiveness to Flicker Light in Primary Open Angle Glaucoma. Metabolites 2022; 12
27.06.2022
Peripapillary Oxygenation and Retinal Vascular Responsiveness to Flicker Light in Primary Open Angle Glaucoma.
27.06.2022

Metabolites 2022; 12

Türksever Cengiz, Todorova Margarita

Weiter
27.06.2022
Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study.
Winter B, Hovaguimian F, Kouyos R, Schmidt A, Bernasconi E, Braun D, Calmy A, Notter J, Stoeckle M, Surial B, Christinet V, Cavassini M, Depmeier C, Läuchli S, Boffi El Amari E, Reinacher M, Rasi M, Bruggmann P, Haerry D, Bize R, Low N, Lehner A, Quednow B, Fehr J, Hampel B. Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study. Swiss Med Wkly 2022; 152:w30192.
27.06.2022
Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study.
27.06.2022

Swiss Med Wkly 2022; 152:w30192

Winter Babette L, Hovaguimian Frédérique, Kouyos Roger D, Schmidt Axel Jeremias, Bernasconi Enos, Braun Dominique L, Calmy Alexandra, Notter Julia, Stoeckle Marcel, Surial Bernard, Christinet Vanessa, Cavassini Matthias, Depmeier Carsten, Läuchli Severin, Boffi El Amari Emmanuelle, Reinacher Matthias, Rasi Manuela, Bruggmann Philip, Haerry David, Bize Raphaël, Low Nicola, Lehner Andreas, Quednow Boris B, Fehr Jan S, Hampel Benjamin

Weiter
24.06.2022
Smartphone-based real-life activity data for physical performance outcome in comparison to conventional subjective and objective outcome measures after degenerative lumbar spine surgery
Voglis S, Stienen M, Weyerbrock A, Bellut D, Regli L, Bozinov O, Sosnova M, Zeitlberger A, Ziga M, Maldaner N. Smartphone-based real-life activity data for physical performance outcome in comparison to conventional subjective and objective outcome measures after degenerative lumbar spine surgery. Brain and Spine 2022
24.06.2022
Smartphone-based real-life activity data for physical performance outcome in comparison to conventional subjective and objective outcome measures after degenerative lumbar spine surgery
24.06.2022

Brain and Spine 2022

Voglis Stefanos, Stienen Martin N., Weyerbrock Astrid, Bellut David, Regli Luca, Bozinov Oliver, Sosnova Marketa, Zeitlberger Anna, Ziga Michal, Maldaner Nicolai

Weiter
24.06.2022
Comparison of temporal evolution of computed tomography imaging features in COVID-19 and influenza infections in a multicenter cohort study.
Fischer T, El Baz Y, Scanferla G, Graf N, Waldeck F, Kleger G, Frauenfelder T, Bremerich J, Kobbe S, Pagani J, Schindera S, Conen A, Wildermuth S, Leschka S, Strahm C, Wälti S, Dietrich T, Albrich W. Comparison of temporal evolution of computed tomography imaging features in COVID-19 and influenza infections in a multicenter cohort study. Eur J Radiol Open 2022; 9:100431.
24.06.2022
Comparison of temporal evolution of computed tomography imaging features in COVID-19 and influenza infections in a multicenter cohort study.
24.06.2022

Eur J Radiol Open 2022; 9:100431

Fischer Tim, El Baz Yassir, Scanferla Giulia, Graf Nicole, Waldeck Frederike, Kleger Gian-Reto, Frauenfelder Thomas, Bremerich Jens, Kobbe Sabine Schmidt, Pagani Jean-Luc, Schindera Sebastian, Conen Anna, Wildermuth Simon, Leschka Sebastian, Strahm Carol, Wälti Stephan, Dietrich Tobias, Albrich Werner

Weiter
23.06.2022
Development of a Score for Prediction of Occult Malignancy in Stroke Patients (Occult-5 Score).
Beyeler M, Birner B, Branca M, Meinel T, Vynckier J, Buffle E, Scutelnic A, Heldner M, Bücke P, Seiffge D, Mordasini P, Dobrocky T, Piechowiak E, Kaesmacher J, Gralla J, Mattle H, Arnold M, Fischer U, Pabst T, Berger M, Jung S. Development of a Score for Prediction of Occult Malignancy in Stroke Patients (Occult-5 Score). J Stroke Cerebrovasc Dis 2022; 31:106609.
23.06.2022
Development of a Score for Prediction of Occult Malignancy in Stroke Patients (Occult-5 Score).
23.06.2022

J Stroke Cerebrovasc Dis 2022; 31:106609

Beyeler Morin, Birner Barbara, Branca Mattia, Meinel Thomas Raphael, Vynckier Jan, Buffle Eric, Scutelnic Adrian, Heldner Mirjam R, Bücke Philipp, Seiffge David Julian, Mordasini Pasquale, Dobrocky Tomas, Piechowiak Eike Immo, Kaesmacher Johannes, Gralla Jan, Mattle Heinrich Paul, Arnold Marcel, Fischer Urs, Pabst Thomas, Berger Martin D, Jung Simon

Weiter
22.06.2022
Treatment during cerebral vasospasm phase-complication association and outcome in aneurysmal subarachnoid haemorrhage.
Hostettler I, Kreiser K, Lange N, Schwendinger N, Trost D, Frangoulis S, Hirle T, Gempt J, Wostrack M, Meyer B. Treatment during cerebral vasospasm phase-complication association and outcome in aneurysmal subarachnoid haemorrhage. J Neurol 2022; 269:5553-5560.
22.06.2022
Treatment during cerebral vasospasm phase-complication association and outcome in aneurysmal subarachnoid haemorrhage.
22.06.2022

J Neurol 2022; 269:5553-5560

Hostettler Isabel C, Kreiser Kornelia, Lange Nicole, Schwendinger Nina, Trost Dominik, Frangoulis Samira, Hirle Theresa, Gempt Jens, Wostrack Maria, Meyer Bernhard

Weiter
20.06.2022
Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas.
Blankenberger J, Kriemler S, Michel G, Rodondi N, Rodondi P, Speierer A, Tancredi S, Puhan M, Kahlert C, Kohler P, Harju E, Fehr J, Kaufmann M, Albanese E, Amati R, Anker D, Camerini A, Chocano-Bedoya P, Cullati S, Cusini A, Corona Immunitas Research Group. Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas. BMC Med 2022; 20:233.
20.06.2022
Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas.
20.06.2022

BMC Med 2022; 20:233

Blankenberger Jacob, Kriemler Susi, Michel Gisela, Rodondi Nicolas, Rodondi Pierre-Yves, Speierer Alexandre, Tancredi Stefano, Puhan Milo A, Kahlert Christian, Kohler Philipp, Harju Erika, Fehr Jan, Kaufmann Marco, Albanese Emiliano, Amati Rebecca, Anker Daniela, Camerini Anne-Linda, Chocano-Bedoya Patricia O, Cullati Stéphane, Cusini Alexia, Corona Immunitas Research Group

Weiter

Wir verwenden Cookies und Tracking-Technologien gemäss unserer Datenschutz- bestimmungen, um Ihnen die bestmögliche Web-Erfahrung zu ermöglichen. Zur Datenschutzerklärung